Jul 4, 2013|
Unilever v/s Procter & Gamble: War of the Worlds
Two FMCG companies, Unilever and Procter & Gamble (P&G) dominate the global consumer goods market. They have not remained untouched from the growing clout of the emerging economies. Going forward, what is their game plan to benefit from the rising importance of developing countries? In this article we delve on the efforts by these companies to raise their share in emerging economies, particularly in India.
A brief background
Internationally, P&G is a much bigger FMCG company having turnover of $ 83.7 bn as compared to turnover of $ 66.7 bn raked in by Unilever. Unilever had commenced operations almost a decade later than the former in 1885. Both of them market home care and personal care products. In case of P&G, these two product segments contribute a lion's share of 75% with the balance coming from over-the-counter healthcare products. For Unilever, home care and personal care account for 53% of sales and the rest 47% comes from foods and refreshments.
Even geographically, the two companies differ in their core markets. In case of Unilever a huge share of 55% of its sales comes from emerging economies. On the other hand, P&G derives a majority 62% of its overall sales from developed markets.
Both companies boast of strong brands. Unilever has brands such as Dove, Axe, Rexona, Vaseline, Lifebuoy, Lux, Ponds, Vaseline, Sunsilk, TRESemme, VO5, Clear, Surf, OMO, CIF, Domestos, Comfort, Lipton, Walls & Knorr. P&G is equipped with brands such as Head & Shoulder, Olay, Pantene, Wella Braun, Gillette, Mach 3, Crest, Oral-B, Ariel, Duracell, Gain, Tide and Pampers.
A look at the financial parameters clearly shows that P&G, backed by better operating leverage, enjoys higher profitability than Unilever. However, Unilever offers better shareholder's returns.
* Year ended March 2012 and † year ending June 2012. For others, figures are for year ended December 2012
|Net profit margin
|Return on equity
|Return on asset
|Debt to equity
Source: Equitymaster Research, Company Annual Reports
Rising power of emerging economies
The onslaught of the global financial crisis in 2008 has led to moderation in consumer demand from developed countries. This development has adversely impacted P&G's topline growth as it still derives a bulk of its sales from the US and other developed markets. In FY12, the company's sales increased by a mere 1.5%.
Developing countries such as China, India and other Asian and African countries have managed to report healthy economic growth. Therefore these countries have been clocking robust growth in consumer goods sales.
For Unilever, emerging economies are already a big market. In CY12, Unilever's turnover increased by 10.5% crossing the $ 50 bn mark. This was achieved by underlying sales growth of 11.4% from emerging markets, even as slower sales from developed market pulled down the overall underlying sales growth to 6.9%.
Faced with slowdown in home markets, global FMCG companies have been vying with each other to raise their share of sales from emerging economies. Unilever wants to further raise the share of sales from emerging markets to 70-75% of turnover by 2020. The company is building 27-28 factories worldwide out of which barring two, all are in the developing economies. P&G wants to expand its sales share from emerging markets to 50% by 2025.
Market dynamics in India
In India, Unilever operates through its subsidiary Hindustan Unilever Ltd (HUL). Hindustan Unilever is the largest consumer goods company in the country with a presence in home care, personal care, foods and beverages. While the company is a market leader in most of the personal care and home care products, it has not gained much success in the foods portfolio. The company has increased focus on its personal care portfolio in the past five years through increased launches. The company has an additional advantage of strong rural reach and products straddling the price pyramid. Unilever is hiking stake in HUL from 52.5% to 75% through an open offer to capitalize on the huge untapped potential..
Procter & Gamble is present through three subsidiaries, Procter & Gamble Hygiene & Healthcare (PGHH), Gillette and Procter & Gamble Home Products (PGHP). Only the first two are listed subsidiaries with the largest one still remaining unlisted. PGHH sells feminine hygiene and healthcare products whereas Gillette markets men grooming products. The unlisted subsidiary, PGHP sells the bulk of personal care and home care products that compete with rival HUL's products. The combined turnover of the Indian business is over $ 1 bn which is around 1% to P&G's overall turnover.
P&G has planned a $1 bn investment plan for India over the next five years spread across capital and marketing investments. The company recently launched toothpaste under the Oral-B brand taking on established players such as Colgate and HUL.
The growing power of emerging economies is forcing a re-think in the strategy of global FMCG majors. Unilever, which has a higher share of its sales from developing countries, has been able to weather the global downturn much better as compared to larger peer P&G.
Both companies have now chalked out plans to expand their market share in the emerging markets. In India markets, Unilever has a formidable presence through strong distribution reach and with products across price points. In comparison, P&G's products are more premium. It remains to be seen, how the two companies battle out to increase their turf.
||Madhu Gupta (Research Analyst), Managing Editor, ResearchPro has a post graduate degree in both physics and finance. Having worked with India's leading economic research agency, she has a natural flair for numbers and analytics. She brings with her a near-decade long rich experience in the field of finance. A firm believer of the principles of value investing, she looks for robust businesses with durable competitive advantages. Madhu contributes towards our small cap service Hidden Treasure.
More Views on News
Aug 9, 2017
While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.
Dec 9, 2016
Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.
Nov 30, 2016
Nestle India declared results for the quarter ended September 2016. Here is our analysis of the result.
Nov 30, 2016
GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.
Nov 28, 2016
Marico has reported a flat topline while the bottomline has grown by 18% YoY during the quarter.
More Views on News
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 10, 2017
Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 10, 2017
Bitcoin hits an all-time high, is there more upside left?
Aug 16, 2017
Ensure your financial Independence, and pledge to start the journey towards financial freedom today!
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407